• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

QBP1 抑制 TDP-43 淀粉样蛋白形成的分子机制。

Molecular mechanism of the inhibition of TDP-43 amyloidogenesis by QBP1.

机构信息

Instituto de Química Física "Rocasolano", CSIC, Serrano 119, Madrid, 28006, Spain.

Instituto Cajal, CSIC, Avda. Doctor Arce 37, Madrid, 28002, Spain.

出版信息

Arch Biochem Biophys. 2019 Oct 30;675:108113. doi: 10.1016/j.abb.2019.108113. Epub 2019 Sep 27.

DOI:10.1016/j.abb.2019.108113
PMID:31568752
Abstract

Transactive Response DNA-Binding Protein of 43 kDa (TDP-43) is an essential human protein implicated in Amyotrophic Lateral Sclerosis (ALS) and common dementias. Its C-terminal disordered region, composed of residues 264-414 includes a hydrophobic segment (residues 320-340), which drives physiological liquid/liquid phase separation and a Q/N-rich segment (residues 341-357), which is essential for pathological amyloid formation. Due to TDP-43's relevance for pathology, identifying inhibitors and characterizing their mechanism of action are important pharmacological goals. The Polyglutamine Binding Peptide 1 (QBP1), whose minimal active core is the octapeptide WGWWPGIF, strongly inhibits the aggregation of polyQ-containing amyloidogenic proteins such as Huntingtin. Rather promiscuous, this inhibitor also blocks the aggregation of other glutamine containing amyloidogenic proteins, but not Aβ, and its mechanism of action remains unknown. Using a series of spectroscopic assays and biochemical tests, we establish that QBP1 binds and inhibits amyloid formation by TDP-43's Q/N-rich region. NMR spectroscopic data evince that the aromatic rings of QBP1 accept hydrogen bonds from the HN groups of the Asn and Gln to block amyloidogenesis. This mechanism of blockage may be general to polyphenol amyloid inhibitors.

摘要

43kDa 转译反应 DNA 结合蛋白(TDP-43)是一种重要的人类蛋白,与肌萎缩性侧索硬化症(ALS)和常见痴呆症有关。其 C 端无规卷曲结构域由残基 264-414 组成,包括一个疏水区(残基 320-340),该区域驱动生理液体/液相分离和一个富含 Q/N 的区域(残基 341-357),对于病理性淀粉样形成是必需的。由于 TDP-43 与病理学有关,因此鉴定抑制剂并描述其作用机制是重要的药理学目标。聚谷氨酰胺结合肽 1(QBP1)的最小活性核心是八肽 WGWWPGIF,它强烈抑制含有聚谷氨酰胺的淀粉样蛋白原纤维形成,如亨廷顿蛋白。这种抑制剂具有较强的非特异性,它还可以阻止其他含有谷氨酰胺的淀粉样蛋白原纤维的聚集,但不能阻止 Aβ的聚集,其作用机制尚不清楚。我们使用一系列光谱测定和生化测试,确定 QBP1 结合并抑制 TDP-43 的富含 Q/N 区域的淀粉样形成。NMR 光谱数据表明,QBP1 的芳环接受来自 Asn 和 Gln 的 HN 基团的氢键,从而阻断淀粉样形成。这种阻断机制可能对多酚类淀粉样抑制剂具有普遍性。

相似文献

1
Molecular mechanism of the inhibition of TDP-43 amyloidogenesis by QBP1.QBP1 抑制 TDP-43 淀粉样蛋白形成的分子机制。
Arch Biochem Biophys. 2019 Oct 30;675:108113. doi: 10.1016/j.abb.2019.108113. Epub 2019 Sep 27.
2
Computational insights into mechanism of AIM4-mediated inhibition of aggregation of TDP-43 protein implicated in ALS and evidence for in vitro inhibition of liquid-liquid phase separation (LLPS) of TDP-43-A315T by AIM4.计算视角下 AIM4 抑制 ALS 相关 TDP-43 蛋白聚集的机制及其体外抑制 TDP-43-A315T 液-液相分离 (LLPS) 的证据。
Int J Biol Macromol. 2020 Mar 15;147:117-130. doi: 10.1016/j.ijbiomac.2020.01.032. Epub 2020 Jan 7.
3
The amyloidogenicity of a C-terminal region of TDP-43 implicated in Amyotrophic Lateral Sclerosis can be affected by anions, acetylation and homodimerization.TDP-43 蛋白 C 端区域与肌萎缩性侧索硬化症有关,其淀粉样变性可以受到阴离子、乙酰化和同源二聚化的影响。
Biochimie. 2018 Jul;150:76-87. doi: 10.1016/j.biochi.2018.05.003. Epub 2018 May 8.
4
The physical forces mediating self-association and phase-separation in the C-terminal domain of TDP-43.TDP-43 C 端结构域介导其自聚集和相分离的物理力。
Biochim Biophys Acta Proteins Proteom. 2018 Feb;1866(2):214-223. doi: 10.1016/j.bbapap.2017.10.001. Epub 2017 Oct 4.
5
Aromatic and aliphatic residues of the disordered region of TDP-43 are on a fast track for self-assembly.TDP-43 无规则区的芳香族和脂肪族残基可快速进行自组装。
Biochem Biophys Res Commun. 2021 Nov 12;578:110-114. doi: 10.1016/j.bbrc.2021.09.040. Epub 2021 Sep 20.
6
NMR spectroscopy reveals a preferred conformation with a defined hydrophobic cluster for polyglutamine binding peptide 1.NMR 光谱揭示了聚谷氨酰胺结合肽 1 具有特定疏水簇的优先构象。
Arch Biochem Biophys. 2014 Sep 15;558:104-10. doi: 10.1016/j.abb.2014.06.025. Epub 2014 Jul 5.
7
Small Molecule Targeting TDP-43's RNA Recognition Motifs Reduces Locomotor Defects in a Model of Amyotrophic Lateral Sclerosis (ALS).小分子靶向 TDP-43 的 RNA 识别结构域可减少肌萎缩侧索硬化症(ALS)模型中的运动缺陷。
ACS Chem Biol. 2019 Sep 20;14(9):2006-2013. doi: 10.1021/acschembio.9b00481. Epub 2019 Aug 27.
8
The β-turn-supporting motif in the polyglutamine binding peptide QBP1 is essential for inhibiting huntingtin aggregation.多聚谷氨酰胺结合肽 QBP1 中的β-转角支持基序对于抑制亨廷顿蛋白聚集是必需的。
FEBS Lett. 2020 Sep;594(17):2894-2903. doi: 10.1002/1873-3468.13873. Epub 2020 Jul 11.
9
Importance of the Q/N-rich segment for protein stability of endogenous mouse TDP-43.Q/N 富含片段对内源性小鼠 TDP-43 蛋白稳定性的重要性。
Sci Rep. 2022 Sep 2;12(1):14923. doi: 10.1038/s41598-022-19153-0.
10
An Amyloid-Like Pathological Conformation of TDP-43 Is Stabilized by Hypercooperative Hydrogen Bonds.TDP-43的一种类淀粉样病理构象通过超协同氢键得以稳定。
Front Mol Neurosci. 2016 Nov 17;9:125. doi: 10.3389/fnmol.2016.00125. eCollection 2016.

引用本文的文献

1
Orientation affects hydrogen bonding cooperativity in polyproline II helical bundles.取向影响多聚脯氨酸II螺旋束中的氢键协同性。
Commun Chem. 2025 Jul 4;8(1):195. doi: 10.1038/s42004-025-01576-1.
2
The Regulation of TDP-43 Structure and Phase Transitions: A Review.TDP-43结构与相变的调控:综述
Protein J. 2025 Apr;44(2):113-132. doi: 10.1007/s10930-025-10261-0. Epub 2025 Feb 22.
3
Hydrogen bonding patterns and cooperativity in polyproline II helical bundles.聚脯氨酸II型螺旋束中的氢键模式与协同性。
Commun Chem. 2024 Aug 30;7(1):191. doi: 10.1038/s42004-024-01268-2.
4
Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS.与超氧化物歧化酶1(SOD1)和TDP - 43相关的肌萎缩侧索硬化症中的蛋白质聚集及治疗策略
Front Mol Biosci. 2024 May 24;11:1383453. doi: 10.3389/fmolb.2024.1383453. eCollection 2024.
5
RNA-binding properties orchestrate TDP-43 homeostasis through condensate formation in vivo.RNA 结合特性通过体内凝聚物的形成来协调 TDP-43 的动态平衡。
Nucleic Acids Res. 2024 May 22;52(9):5301-5319. doi: 10.1093/nar/gkae112.
6
Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD.肌萎缩侧索硬化症/额颞叶痴呆中 TDP-43 蛋白病的新兴治疗方法和新靶点。
Neurotherapeutics. 2022 Jul;19(4):1061-1084. doi: 10.1007/s13311-022-01260-5. Epub 2022 Jul 5.
7
Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases.基于纳米技术的药物递送策略修复神经炎症和神经退行性疾病中的线粒体功能
Pharmaceutics. 2021 Dec 1;13(12):2055. doi: 10.3390/pharmaceutics13122055.
8
Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases.蛋白质聚集抑制剂作为聚谷氨酰胺疾病的疾病修饰疗法
Front Neurosci. 2021 Feb 12;15:621996. doi: 10.3389/fnins.2021.621996. eCollection 2021.